Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
NASDAQ:ITRM
Price:
0.1788
USD
7.71%
Market Closed
Market Cap:
$9.5m
Relative Value
The Relative Value of one
ITRM
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.1788 USD,
Iterum Therapeutics PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ITRM Relative Value
HIDDEN
Multiples Across Competitors
ITRM Competitors Multiples
Iterum Therapeutics PLC Competitors
Iterum Therapeutics PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IE |
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
8.8m USD | 22.5 | -0.3 | -1.6 | -1.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
952.7B USD | 14.6 | 46.2 | 31.1 | 33.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
584.1B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
262.5B CHF | 4.3 | 20.4 | 12 | 13.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
238.2B CHF | 5.5 | 22.1 | 13.7 | 17.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.5B GBP | 5.1 | 29.3 | 16.2 | 22.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
289.8B USD | 4.5 | 15.9 | 9.9 | 12 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.9 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.4B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
